Cardinal Health, Inc. CAH
Set alert
As of Nov 2, 10:54 AM ET
- YTD
- +23.77%
- 1 year
- +33.33%
- Open
- 251.48
- Prev close
- 250.48
- Mkt cap
- 58.88B
- Vol
- 383.76K
- Avg vol
- 1.78M
- EPS
- 7.23
- P/E
- 35.17
- Div yield
- 0.82%
More statistics
- Low
- 248.90
- High
- 255.15
- Forward P/E
- 17.82
- Beta
- 0.50
- Short ratio
- 4.16
- Inst. own
- 91.43%
- Dividend
- 2.06
- Ex-div date
- Sep 30, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 237.33
- 200-d avg
- 221.97
- 1y target
- 273.47
5D chart
Events in this range
- Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
Signals (125)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 10:45 AM | 9 minutes ago |
| RSI: Overbought | Nov 2, 10:15 AM | 39 minutes ago |
| SMA: Bullish | Nov 2, 10:10 AM | 44 minutes ago |
| SMA: Bullish | Nov 2, 9:55 AM | 59 minutes ago |
| MACD: Buy Signal | Nov 2, 9:55 AM | 59 minutes ago |
| MACD: Sell Signal | Nov 2, 9:50 AM | 1 hour ago |
| SMA: Bearish | Nov 2, 9:40 AM | 1 hour ago |
| RSI: Oversold | Nov 2, 9:40 AM | 1 hour ago |
| SMA: Bullish | Nov 2, 9:30 AM | 1 hour ago |
| MACD: Buy Signal | Oct 30, 3:55 PM | 2 days ago |
| RSI: Oversold | Oct 30, 3:00 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:40 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:30 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:35 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:30 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:00 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:45 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:00 AM | 3 days ago |
| RSI: Overbought | Oct 30, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:15 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:10 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 11:00 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 10:55 AM | 4 days ago |
| RSI: Overbought | Oct 29, 10:50 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:45 AM | 4 days ago |
| RSI: Overbought | Oct 29, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:35 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:30 AM | 4 days ago |
| RSI: Overbought | Oct 29, 10:10 AM | 4 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:45 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:15 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:45 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:25 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:00 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:00 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:50 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:50 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:40 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 10:00 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 5 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:20 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:40 AM | 6 days ago |
News
2 hours ago zacks.com
Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?
Cardinal Health CAH is scheduled to report first-quarter fiscal 2027 results on Nov. 5, before the market opens. The company entered the quarter with strong pharmaceutical demand, expanding specialty…
-
2 days ago benzinga.com
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $286
Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $265 to $286.
5 days ago zacks.com
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Cardinal Health (CAH) reached $246.45 at the closing of the latest trading day, reflecting a -2.02% change compared to its last close.
1 week ago seekingalpha.com
The Dividend Aristocrats Ranked By Quality Scores (October 2026)
I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data…
1 week ago zacks.com
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.
-
1 week ago benzinga.com
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.
-
2 weeks ago benzinga.com
UBS Maintains Buy on Cardinal Health, Raises Price Target to $295
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.
2 weeks ago zacks.com
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) closed at $253.71 in the latest trading session, marking a +2.41% move from the prior day.
2 weeks ago zacks.com
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.
2 weeks ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 weeks ago zacks.com
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2 weeks ago zacks.com
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
2 weeks ago zacks.com
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.
3 weeks ago zacks.com
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.
3 weeks ago zacks.com
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know
Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.
3 weeks ago defenseworld.net
Cardinal Health, Inc. $CAH Position Decreased by Park National Corp OH
Park National Corp OH trimmed its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 8.1% during the third quarter, according to the company in its most recent Form 13F filing with the…
4 weeks ago defenseworld.net
MassMutual Private Wealth & Trust FSB Buys 106,709 Shares of Cardinal Health, Inc. $CAH
MassMutual Private Wealth and Trust FSB increased its stake in Cardinal Health, Inc. (NYSE: CAH) by 6,447.7% during the undefined quarter, according to the company in its most recent 13F filing with…
1 month ago benzinga.com
Cardinal Health, McKesson Double Down on CVS Deals Through 2032
Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.
1 month ago zacks.com
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
-
1 month ago benzinga.com
Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032
Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the…
1 month ago prnewswire.com
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS…
1 month ago prnewswire.com
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the…
1 month ago seekingalpha.com
Cardinal Health: I'm Still Buying After Checking The Numbers
Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. CAH delivered 14% revenue growth, 20% gross margin expansion, and doubled free cash…
1 month ago zacks.com
At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend?
At-Home Solutions is powering CAH???s growth strategy as investments, acquisitions and technology help it scale in home-based healthcare.
1 month ago zacks.com
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.
1 month ago zacks.com
Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?
CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.
1 month ago zacks.com
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
1 month ago benzinga.com
9 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
2 months ago benzinga.com
RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276
RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.
-
2 months ago benzinga.com
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280
TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.
-
2 months ago benzinga.com
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260
JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.
-
2 months ago benzinga.com
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275
Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.
-
2 months ago benzinga.com
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270
Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.
-
2 months ago benzinga.com
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265
Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.
-
2 months ago benzinga.com
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $240 to $250.
-
2 months ago benzinga.com
UBS Maintains Buy on Cardinal Health, Raises Price Target to $280
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $274 to $280.
2 months ago benzinga.com
Cardinal Health Analysts Increase Their Forecasts Following Q4 Results
Cardinal Health posted mixed Q4 results, with adjusted earnings of $2.91 per share beating estimates, but sales missing expectations. The company also raised its share repurchase authorization and…
-
2 months ago benzinga.com
Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $277
Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $245 to $277.
-
2 months ago benzinga.com
Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $251 to $274.
2 months ago benzinga.com
S&P 500 Falls for Second Session Ahead of Inflation Report: Investor Sentiment Weakens, Fear & Greed Index Remains in ‘Greed’ Zone
CNN Fear & Greed Index: Market sentiment declined, but remained in Greed zone on Tuesday. Stocks closed lower.
2 months ago benzinga.com
Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market
CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and approves a $5B buyback expansion.
2 months ago benzinga.com
US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results
US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.
-
2 months ago benzinga.com
Cardinal Health Announces $5B Incremental Share Buyback Authorization
Cardinal Health recently completed an additional $350 million accelerated share repurchase program, bringing year-to-date share repurchases in fiscal year 2026 to $1.4 billion.Cardinal Health Board…
2 months ago benzinga.com
Dow Falls Over 50 Points Ahead of Inflation Data: Fear Index Remains in ‘Greed’ Zone
Stocks closed mostly lower on Monday, with the Fear and Greed index remaining in Greed zone. Investors await earnings results and CPI report.
2 months ago benzinga.com
Cardinal Health, Babcock & Wilcox Enterprises and 3 Stocks to Watch Heading Into Tuesday
U.S. stock futures mixed, focus on Super Micro Computer Inc, Upwork Inc, Cardinal Health Inc, Babcock & Wilcox Enterprises Inc.
-
2 months ago benzinga.com
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
CAH to release Q4 earnings on Aug. 11, analysts expect EPS of $2.42 and revenue of $65.11B. Recently acquired diabetes health business for $360M.
2 months ago benzinga.com
Lumentum Could Swing $9.74 Billion After Earnings
Earnings set to hit the tape Tues. Options market implying post-print swings for 5 stocks, from healthcare to AI. Cardinal Health has biggest move at 6.83%.
-
3 months ago benzinga.com
Citigroup Maintains Buy on Cardinal Health, Raises Price Target to $265
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $245 to $265.
-
3 months ago benzinga.com
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $240
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $235 to $240.
-
3 months ago benzinga.com
Cardinal Health To Acquire The Diabetes Health Business Of Adapthealth And, In Its Entirety, Strive Medical For ~$360M In Cash
Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology.…